Capstone Investment Advisors (Netherlands)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$405K Buy
1,664
+757
+83% +$178K 1.41% 12
2017
Q1
$217K Buy
+907
New +$211K 0.61% 88

Other funds holding AGN

Capstone Investment Advisors (Netherlands)'s AGN Position: Q2 2017 in Review

Capstone Investment Advisors (Netherlands) increased its Allergan plc (AGN) stake by 83% in Q2 2017, buying an estimated $178K and bringing the position to 1,664 shares worth $405K. The position accounts for 1.41% of the portfolio, ranked #12.

Capstone Investment Advisors (Netherlands) first reported a position in AGN in Q1 2017 and has held it in 2 quarters since. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Capstone Investment Advisors (Netherlands) held 1,664 shares of Allergan plc worth $405K as of Q2 2017.
  • Capstone Investment Advisors (Netherlands) bought 757 Allergan plc shares in Q2 2017, an estimated $178K.
  • Allergan plc made up 1.41% of Capstone Investment Advisors (Netherlands)'s portfolio in Q2 2017, its #12 holding.
  • Capstone Investment Advisors (Netherlands) first reported a position in Allergan plc in Q1 2017 and has held it in 2 quarters since.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Capstone Investment Advisors (Netherlands)'s 13F filing for Q2 2017, filed 14 Aug 2017.